PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29269881-0	2017	Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation.	Fatty Acids	107-117	albumin	Homo sapiens	58-71	
29269881-2	2017	Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was developed as a technique to extend the serum half-life in vivo by taking advantages of unusually long serum half-life of human serum albumin (HSA).	Fatty Acids	15-25	albumin	Homo sapiens	43-56	
29269881-2	2017	Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was developed as a technique to extend the serum half-life in vivo by taking advantages of unusually long serum half-life of human serum albumin (HSA).	Fatty Acids	15-25	albumin	Homo sapiens	229-242